JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, GM-CSF-supplemented CML CD34+ cells could dose-dependently recover BCR-ABL-independent JAK2/STAT5 phosphorylation in monolayer medium (Fig. 3D, E).